Trends in Cardiovascular Medicine
Volume 16, Issue 2 , Pages 50-55, February 2006

Caveolin-1: Dual Role for Proliferation of Vascular Smooth Muscle Cells

  • Daniel G. Sedding
  • ,
  • Ruediger C. Braun-Dullaeus

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Ruediger C. Braun-Dullaeus, MD, Department of Internal Medicine/Cardiology, Dresden University of Technology, Fetscherstrasse 76, D-01307 Dresden, Germany. Tel.: (+49) 351-450-1701; fax: (+49) 351-450-1702.

Department of Biochemistry, Giessen University, Giessen, Germany

Department of Internal Medicine I/Cardiology, Giessen University, Giessen, Germany

Department of Internal Medicine/Cardiology, Dresden University of Technology, D-01307 Dresden, Germany

Although caveolae function in vesicular and cholesterol trafficking, the recent identification of various signaling molecules in caveolae and their functional interaction with caveolin suggest that they may participate in transmembrane signaling. Interestingly, many of the signaling molecules that interact with caveolin-1 (cav-1) mediate mitogenic signals to the nucleus, implying that cav-1 may play a modulating role in the pathophysiology of vascular proliferative diseases such as atherosclerosis and restenosis after angioplasty. Although much attention has been given to the predominantly antiproliferative role of cav-1 in growth-factor-induced signal transduction, we were recently able to demonstrate that cav-1 acts in mechanotransduction too. During cyclic strain, however, cav-1 is critically involved in proproliferative signaling. We propose that, at least in the vasculature which is constantly exposed to alternating mechanical force and different growth factors, cav-1 holds a dual role toward modulation of proliferation, depending on the stimulus the cells are exposed to. In vivo, the net effect of growth factors and mechanically triggered stimuli determines the amount of local cell proliferation and, therefore, the onset and progression of vascular proliferative disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(05)00221-5

doi:10.1016/j.tcm.2005.11.007

Trends in Cardiovascular Medicine
Volume 16, Issue 2 , Pages 50-55, February 2006